Portfolio

Sensorium Therapeutics Appoints Veteran Life Sciences Executive Mr. David Southwell to its Board of Directors

BOSTON, Sept. 12, 2023 (GLOBE NEWSWIRE) — Sensorium Therapeutics (Sensorium), a biotechnology company translating insights from nature and human experience to deliver transformational therapeutics, today announced the appointment of veteran life sciences executive David Southwell to its Board of Directors. “We are excited to welcome David to our Board,” said Dick Simon, Chief Executive Officer …

Sensorium Therapeutics Appoints Veteran Life Sciences Executive Mr. David Southwell to its Board of Directors Read More »

Solu Therapeutics Names Philip Vickers President and CEO

Solu Therapeutics, a precision-medicine company developing therapeutics to eliminate disease-driving cells, appointed Philip Vickers, President, and Chief Executive Officer. Vickers succeeds David Donabedian, co-founder, and start-up CEO of the company. Vickers has more than 30 years of experience in the biopharma industry. As CEO, he will play an instrumental role in the company’s work to eliminate …

Solu Therapeutics Names Philip Vickers President and CEO Read More »

Glyscend Therapeutics Appoints Sapan A. Shah, Ph.D., Accomplished Industry Executive, as Chief Executive Officer

Planned Leadership Transition to Accelerate the Company’s Next Stage of Growth; Founding CEO Ashish Nimgaonkar, M.D., Transitions to Chief Medical Officer and Head of R&D Lead Candidate, GLY-200, Ready to Begin Phase 2b Development for Obesity and Type 2 Diabetes BOSTON–(BUSINESS WIRE)–Glyscend Therapeutics, a clinical-stage biopharmaceutical company that is reshaping the treatment of metabolic disease, …

Glyscend Therapeutics Appoints Sapan A. Shah, Ph.D., Accomplished Industry Executive, as Chief Executive Officer Read More »

Boston Scientifics Farapulse Pulsed Field Ablation System Revolutionizing Cardiac Care

On August 28, 2023, Boston Scientific unveiled its revolutionary Farapulse Pulsed Field Ablation system, a cutting-edge therapy designed to selectively ablate heart tissue in atrial fibrillation patients. This groundbreaking technology has been proven to be as effective as the current standard-of-care treatments, radiofrequency, and cryoablation, as demonstrated by the ADVENT study. The promising results from this study are expected …

Boston Scientifics Farapulse Pulsed Field Ablation System Revolutionizing Cardiac Care Read More »

Geneos Therapeutics Announces Eight of 34 Patients to Achieve Complete Response, Complete Molecular Response, or, Secondary Resectability in Ongoing Clinical Trial of Personalized Therapeutic Cancer Vaccination in Second Line Advanced Liver Cancer

By RECIST1.1, Three Complete Responses and Seven Durable Partial Responses Achieved to Date Three of the Seven Patients With Durable Partial Responses, and One With Stable Disease, Have Now Achieved Complete Molecular Response By Ultrasensitive ctDNA Analysis  No Serious Adverse Events Related to Cancer Vaccine, Related Adverse Events Grades 1 and 2 Only PLYMOUTH MEETING, …

Geneos Therapeutics Announces Eight of 34 Patients to Achieve Complete Response, Complete Molecular Response, or, Secondary Resectability in Ongoing Clinical Trial of Personalized Therapeutic Cancer Vaccination in Second Line Advanced Liver Cancer Read More »

Boston Scientific’s Farapulse PFA system is poised for FDA approval, analysts say

Boston Scientific’s Farapulse pulsed-field ablation (PFA) system likely hit its primary endpoints, according to Needham analysts who say that means the technology is poised for FDA approval. Boston Scientific has already said it expects FDA approval of Farapulse next year, but has not yet shared results from its ADVENT pivotal trial. That data is set …

Boston Scientific’s Farapulse PFA system is poised for FDA approval, analysts say Read More »

CareHive continues to lead the way with 3-pronged technology approach – For Health plans, patients, and at-risk providers

CareHive, a leader in the health technology landscape, is transforming healthcare delivery through its pioneering 3-pronged technology approach — an initiative designed to revolutionize healthcare plans, amplify patient care, and support at-risk providers. Houston, TX – CareHive, a leader in the health technology landscape, is transforming healthcare delivery through its pioneering 3-pronged technology approach — an initiative designed …

CareHive continues to lead the way with 3-pronged technology approach – For Health plans, patients, and at-risk providers Read More »

Solu Therapeutics Debuts with $31 Million in Seed Funding to Unlock Antibody-Intractable Cell Surface Targets

Clinical candidate selected, initially targeting hematological malignancies BOSTON–(BUSINESS WIRE)–Solu Therapeutics, a precision-medicine company developing therapeutics to eliminate disease-driving cells, founded by Longwood Fund, today announced the closing of an oversubscribed $31 million seed financing co-led by Longwood and Santé Ventures, with additional participation from DCVC Bio, Astellas Venture Management, and Alexandria Venture Investments. The proceeds …

Solu Therapeutics Debuts with $31 Million in Seed Funding to Unlock Antibody-Intractable Cell Surface Targets Read More »

Geneos Therapeutics Nominated for 2023 Prix Galien USA Startup Award

Nomination Recognizes Progress and Promise of Geneos’ Personalized Therapeutic Cancer Vaccines PLYMOUTH MEETING, Pa., July 28, 2023 /PRNewswire/ — Geneos Therapeutics, a clinical stage biotherapeutics company focused on the development of personalized therapeutic cancer vaccines (PTCV), today announced that it has been nominated for the Prix Galien Startup Award for 2023. The Galien Foundation is the premier global …

Geneos Therapeutics Nominated for 2023 Prix Galien USA Startup Award Read More »

New weight loss drugs: biotech’s mission to end obesity

Obesity has nearly tripled since 1975, becoming an ever-growing health threat. In 2016, it was estimated that more than 1.9 billion adults in the world were overweight, with more than 650 million of those being officially obese.  Obesity can be defined as abnormal or excessive fat accumulation that presents a risk to health, with a …

New weight loss drugs: biotech’s mission to end obesity Read More »

Boston Scientific raises full-year forecast again, fueled by strong Q2

The company boosted its outlook for the second consecutive quarter and said patients face waitlists for procedures using its devices. Boston Scientific posted higher quarterly sales that exceeded its expectations and boosted its full-year outlook for the second straight quarter, citing broad-based demand amid a healthy market for its medical devices. Total sales in the …

Boston Scientific raises full-year forecast again, fueled by strong Q2 Read More »

Reimagine Care and Memorial Hermann Health System Partner to Advance Cancer Care at Home

NASHVILLE, TN – Reimagine Care, the nation’s leading provider of cancer care services in the home, is announcing a new partnership with Houston-based Memorial Hermann Health System to offer 24/7 access to Reimagine Care’s experienced oncology nurses and advanced practitioners via text, phone, and video, as well as in-home supportive care when appropriate. Reimagine Care’s proactive …

Reimagine Care and Memorial Hermann Health System Partner to Advance Cancer Care at Home Read More »

‘Changing Health Care Is Hard’: Reimagine Care CEO Sets Out To Solve At-Home Cancer Care

Reimagine Care is hoping to become a trailblazer in the at-home cancer care industry, and things are moving fast. Dan Nardi, the company’s new CEO, will be in charge of ensuring things stay on track amid the chaos and excitement. “I’m two weeks in and so personally, the biggest challenge for me is all about …

‘Changing Health Care Is Hard’: Reimagine Care CEO Sets Out To Solve At-Home Cancer Care Read More »

Reimagine Care and DispatchHealth Partner to Support Cancer Care at Home

92% of patients with cancer report they wish to have on-call access to oncology experts and 82% prefer to receive care at home1. This innovative partnership addresses both. NASHVILLE, Tenn. and DENVER, July 18, 2023 /PRNewswire/ — Reimagine Care and DispatchHealth today announced a partnership to improve the lives of patients with cancer by extending comprehensive care beyond brick-and-mortar facilities. The collaboration also …

Reimagine Care and DispatchHealth Partner to Support Cancer Care at Home Read More »

Black Box Technology Shines Light on Improving OR Safety, Efficiency

“Improving surgical care requires access to high-quality data from one of the most secretive environments in modern society—the operating room (OR),” said Teodor Grantcharov, MD, PhD, FACS, inventor of the OR Black Box.   Inspired by the aviation industry’s black box, which helps transportation investigators determine the cause of an adverse event, the OR Black …

Black Box Technology Shines Light on Improving OR Safety, Efficiency Read More »

Novartis strengthens commitment to Beacon of Hope initiative, engages new collaborators to support clinical trial diversity, break down economic and education barriers

Advarra, Virb and BeeKeeperAI sign on to Beacon of Hope to provide suite of digital tools to facilitate clinical trials and research on healthcare inequities at Historically Black Medical School Centers of Excellence  Global Black Economic Forum lends support to Beacon of Hope to address economic disparities that disproportionately impact diverse communities of color around …

Novartis strengthens commitment to Beacon of Hope initiative, engages new collaborators to support clinical trial diversity, break down economic and education barriers Read More »

BeeKeeperAI Raises $12.1 Million Series A to Accelerate AI Development on Privacy Protected Healthcare Data

SAN FRANCISCO, Calif. – June 27, 2023 – BeeKeeperAI, Inc., a pioneer in zero-trust, collaboration software for the development and deployment of artificial intelligence (AI), today announced that it has closed $12.1 million in Series A financing. The round was led by Santé Ventures, with participation from the Icahn School of Medicine at Mount Sinai, AIX …

BeeKeeperAI Raises $12.1 Million Series A to Accelerate AI Development on Privacy Protected Healthcare Data Read More »

Dallas-Based Healthcare IT and Financial Company Uses Technology to Help Improve Transparency for Everyone

Using technology and in-house solutions, REVELOHEALTH™ is changing the game for transparency in healthcare. DALLAS, TEXAS, UNITED STATES, June 6, 2023/EINPresswire.com/ — Designed to sit at the intersection of managed care, payer contracting, and revenue cycle management, REVELOHEALTH™ has been innovating the financial and analytical side of our healthcare system since 2020. Partnering with essential technology …

Dallas-Based Healthcare IT and Financial Company Uses Technology to Help Improve Transparency for Everyone Read More »

Glyscend Therapeutics Announces Positive Topline Phase 2a Clinical Results and Progress with GLY-200, a First-in-Class Treatment for Type 2 Diabetes and Obesity

Phase 2a Data Show that GLY-200 Treatment Led to Significant Reductions in Postprandial Glucose and Body Weight in Patients with Type 2 Diabetes Phase 1 Biomarker Results Were Consistent with those Observed Following Metabolic Surgery and the Use of Duodenal Exclusion Devices; Data to be Presented in Oral and Poster Sessions during the American Diabetes Association …

Glyscend Therapeutics Announces Positive Topline Phase 2a Clinical Results and Progress with GLY-200, a First-in-Class Treatment for Type 2 Diabetes and Obesity Read More »

Scroll to Top